Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2015

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    OA01 - Real World Data to Guide Our Daily Needs

    • 10:45 - 11:45
    • 8/07/2022
    • Location: Strauss 3
    • Not for CME Credit
    • Type: Oral
    • Track: Global Health, Health Services Research, and Health Economics
    • +

      OA01.05 - Socio-economic Inequalities in NSCLC Treatment During the Era of Tumour Biomarker Guided Therapy: A Population-based Study

      11:07 - 11:17  |  Presenter: Ruth Pamela Norris

      • Abstract

      Loading...

  • +

    OA02 - From Locally Advanced to Unresectable NSCLC: Improvement of Multimodality Treatment

    • 12:00 - 13:00
    • 8/07/2022
    • Location: Hall C7
    • Not for CME Credit
    • Type: Oral
    • Track: Locally Advanced Non-small Cell Lung Cancer
    • +

      Session Moderator

      12:00 - 12:00  |  Presenter: Luis Paz-Ares

      • Abstract

      Loading...

    • +

      Session Moderator

      12:00 - 12:00  |  Presenter: Isabelle Opitz

      • Abstract

      Loading...

    • +

      OA02.01 - Session Introduction

      12:00 - 12:01  |  Presenter: Isabelle Opitz

      • Abstract

      Loading...

    • +

      OA02.02 - Session Introduction

      12:01 - 12:02  |  Presenter: Luis Paz-Ares

      • Abstract

      Loading...

    • +

      OA02.03 - Tumor Bulk-RNA Seq Identifies Patients at High Risk of Progression in Non-complete Pathological Responders from NADIM Trial

      12:02 - 12:12  |  Presenter: Marta Casarrubios

      • Abstract

      Loading...

    • +

      OA02.04 - Multimodal Management of T4 N2 Non-small-cell Lung Cancer with Additional Ipsilateral Pulmonary Nodules

      12:12 - 12:22  |  Presenter: Arvind Kumar

      • Abstract

      Loading...

    • +

      OA02.05 - Sugemalimab vs Placebo after cCRT or sCRT in pts with Unresectable Stage III NSCLC: Final PFS Analysis of a Phase 3 Study

      12:22 - 12:32  |  Presenter: Yi-Long Wu

      • Abstract

      Loading...

    • +

      OA02.06 - Discussant

      12:32 - 12:42  |  Presenter: Linda Martin

      • Abstract

      Loading...

    • +

      OA02.07 - Live Q&A

      12:42 - 13:00

      • Abstract

      Loading...

  • +

    OA03 - Molecular Targeted Treatments

    • 14:30 - 15:40
    • 8/07/2022
    • Location: Hall C7
    • Not for CME Credit
    • Type: Oral
    • Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
    • +

      OA03.03 - Sotorasib in Combination with RMC-4630, a SHP2 Inhibitor, in KRAS p.G12C-Mutated NSCLC and Other Solid Tumors

      14:32 - 14:42  |  Presenter: Gerald Falchook

      • Abstract

      Loading...

    • +

      OA03.04 - Phase I A Study to Evaluate GDC-6036 Monotherapy in Patients with Non-small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation

      14:42 - 14:52  |  Presenter: Adrian Sacher

      • Abstract

      Loading...

    • +

      OA03.05 - Tepotinib in Patients with MET Exon 14 (METex14) Skipping NSCLC: Primary Analysis of the Confirmatory VISION Cohort C

      14:52 - 15:02  |  Presenter: Michael Thomas

      • Abstract

      Loading...

    • +

      OA03.06 - CodeBreaK 100/101: First Report of Safety/Efficacy of Sotorasib in Combination with Pembrolizumab or Atezolizumab in Advanced KRAS p.G12C NSCLC

      15:02 - 15:12  |  Presenter: Bob T. Li

      • Abstract

      Loading...

  • +

    OA07 - Is There Still a Role for Chemotherapy Alone in the Management of NSCLC?

    • 11:00 - 12:00
    • 8/08/2022
    • Location: Hall C7
    • Not for CME Credit
    • Type: Oral
    • Track: Metastatic Non-small Cell Lung Cancer - Palliative Chemotherapy
    • +

      Session Moderator

      11:22 - 11:32  |  Presenter: Lubos Petruzelka

      • Abstract

      Loading...

    • +

      Session Moderator

      11:22 - 11:32  |  Presenter: Pilar Garrido

      • Abstract

      Loading...

    • +

      OA07.01 - Session Introduction

      11:00 - 11:01  |  Presenter: Lubos Petruzelka

      • Abstract

      Loading...

    • +

      OA07.02 - Session Introduction

      11:01 - 11:02  |  Presenter: Pilar Garrido

      • Abstract

      Loading...

    • +

      OA07.03 - Association Between Genetic Variation in the ATP-binding Cassette Transporter ABCC10 and nab-PTX Treatment in Japanese Cohort

      11:02 - 11:12  |  Presenter: Minoru Horiuchi

      • Abstract

      Loading...

    • +

      OA07.04 - Overall Survival in Patients With Advanced NSCLC Receiving Taxane-Containing Regimen After Exposure to Immunotherapy and Platinum-Doublet

      11:12 - 11:22  |  Presenter: Stephen V. Liu

      • Abstract

      Loading...

    • +

      OA07.05 - Gemcitabine Plus Platinum Chemotherapy Re-challenge in Metastatic Pulmonary Lymphoepithelioma-like Carcinoma

      11:22 - 11:32  |  Presenter: Gavin Tin Chun Cheung

      • Abstract

      Loading...

    • +

      OA07.06 - Second Line Treatment Outcomes After Progression on Immunotherapy Plus Chemotherapy (IO-CT) In Advanced Non-small Cell Lung Cancer (aNSCLC)

      11:32 - 11:42  |  Presenter: Edouard Auclin

      • Abstract

      Loading...

    • +

      OA07.07 - Discussant

      11:42 - 11:52  |  Presenter: Navneet Singh

      • Abstract

      Loading...

    • +

      OA07.08 - Live Q&A

      11:52 - 12:00

      • Abstract

      Loading...

  • +

    OA09 - Precision Immunotherapy via Modulation of the Tumor Microenvironment

    • 14:45 - 15:45
    • 8/08/2022
    • Location: Lehar 1
    • Not for CME Credit
    • Type: Oral
    • Track: Tumor Biology and Biomarkers
    • +

      OA09.05 - Neoadjuvant IL-15-PDL1 Antibody Promotes T cell Memory and Decreases Metastatic Recurrence in Resectable NSCLC

      15:07 - 15:17  |  Presenter: Jonathan Villena-Vargas

      • Abstract

      Loading...

  • +

    OA11 - Optimal Patient Selection for Local Therapy in Stage IV NSCLC

    • 16:00 - 17:00
    • 8/08/2022
    • Location: Hall C7
    • Not for CME Credit
    • Type: Oral
    • Track: Metastatic Non-small Cell Lung Cancer - Oligometastatic Disease
    • +

      Session Moderator

      16:12 - 16:22  |  Presenter: Pablo Munoz-Schuffenegger

      • Abstract

      Loading...

    • +

      Session Moderator

      16:12 - 16:22  |  Presenter: Mariana Brandao

      • Abstract

      Loading...

    • +

      OA11.01 - Session Introduction

      16:00 - 16:01  |  Presenter: Pablo Munoz-Schuffenegger

      • Abstract

      Loading...

    • +

      OA11.02 - Session Introduction

      16:01 - 16:02  |  Presenter: Mariana Brandao

      • Abstract

      Loading...

    • +

      OA11.03 - Nonregional Lymph Nodes as the Only Metastatic Site in Stage IV Non-Small Cell Lung Cancer: A Marker of Better Prognosis

      16:02 - 16:12  |  Presenter: Peter Lee Zhan

      • Abstract

      Loading...

    • +

      OA11.04 - The Factors Associated With Reduced Risk of Progression in Patients With Oligometastatic NSCLC Treated With Local Ablative Radiotherapy

      16:12 - 16:22  |  Presenter: Gowoon Yang

      • Abstract

      Loading...

    • +

      OA11.05 - Treatment Strategies Based on Different Oligoprogressive Patterns after Immunotherapy Resistance in Advanced NSCLC

      16:22 - 16:32  |  Presenter: Shun Lu

      • Abstract

      Loading...

    • +

      OA11.06 - Sequencing of ctDNA Revealed Radiotherapeutic Efficacy and Prognosis in Non-small Cell Lung Cancer Patients with Brain Metastasis

      16:32 - 16:42  |  Presenter: Xiaorong Dong

      • Abstract

      Loading...

    • +

      OA11.07 - Discussant

      16:42 - 16:52  |  Presenter: Digambar Behera

      • Abstract

      Loading...

    • +

      OA11.08 - Live Q&A

      16:52 - 17:00

      • Abstract

      Loading...

  • +

    OA13 - Evolving Epidemiology of Lung Cancer Beyond Tobacco

    • 10:45 - 11:45
    • 8/09/2022
    • Location: Hall C8
    • Not for CME Credit
    • Type: Oral
    • Track: Epidemiology
    • +

      OA13.04 - Prevalence of Molecular Alterations in NSCLC and Estimated Indoor Radon in Europe: RADON EUROPE Study

      10:57 - 11:07  |  Presenter: Miguel Garcia Pardo

      • Abstract

      Loading...

  • +

    OA14 - New Techniques to Improve Outcome in Early Stage NSCLC Patients Treated with Surgery or Radiotherapy

    • 12:00 - 13:00
    • 8/09/2022
    • Location: Hall C8
    • Not for CME Credit
    • Type: Oral
    • Track: Early Stage Non-small Cell Lung Cancer
    • +

      Session Moderator

      12:00 - 12:00  |  Presenter: Paul Van Schil

      • Abstract

      Loading...

    • +

      Session Moderator

      12:00 - 12:00  |  Presenter: Fabio Moraes

      • Abstract

      Loading...

    • +

      OA14.01 - Session Introduction

      12:00 - 12:01  |  Presenter: Paul Van Schil

      • Abstract

      Loading...

    • +

      OA14.02 - Session Introduction

      12:01 - 12:02  |  Presenter: Fabio Moraes

      • Abstract

      Loading...

    • +

      OA14.04 - Chest Wall Toxicity after Individualized Stereotactic Ablative Radiotherapy for Lung Tumors

      12:02 - 12:12  |  Presenter: Brianna Lau

      • Abstract

      Loading...

    • +

      OA14.05 - Intraoperative Molecular Imaging Guided Resection of CEACAM5+ Lung Tumors: First In-Human SGM-101 Lung Cancer Surgical Trial

      12:12 - 12:22  |  Presenter: Feredun Azari

      • Abstract

      Loading...

    • +

      OA14.06 - T-Cell Dynamics in Response to Neoadjuvant Atezolizumab in Early NSCLC by Antigen Response and T-Cell Receptor Sequencing

      12:22 - 12:32  |  Presenter: Filiz Oezkan

      • Abstract

      Loading...

    • +

      OA14.07 - Discussant

      12:32 - 12:42  |  Presenter: Brendon Stiles

      • Abstract

      Loading...

    • +

      OA14.08 - Live Q&A

      12:42 - 13:00

      • Abstract

      Loading...

  • +

    OA15 - Patient Selection in Advanced NSCLC Immunotherapy

    • 14:30 - 15:30
    • 8/09/2022
    • Location: Hall C7
    • Not for CME Credit
    • Type: Oral
    • Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
    • +

      Session Moderator

      14:32 - 00:00  |  Presenter: Pilar Garrido

      • Abstract

      Loading...

    • +

      Session Moderator

      14:32 - 00:00  |  Presenter: António Araújo

      • Abstract

      Loading...

    • +

      OA15.01 - Session Introduction

      14:30 - 14:31  |  Presenter: Pilar Garrido

      • Abstract

      Loading...

    • +

      OA15.02 - Session Introduction

      14:31 - 14:32  |  Presenter: António Araújo

      • Abstract

      Loading...

    • +

      OA15.03 - Avelumab vs Chemotherapy for First-line Treatment of Advanced PD-L1+ NSCLC: Primary Analysis from JAVELIN Lung 100

      14:32 - 14:42  |  Presenter: Martin Reck

      • Abstract

      Loading...

    • +

      OA15.04 - Association Between KRAS/STK11/KEAP1 Mutations and Outcomes in POSEIDON: Durvalumab ± Tremelimumab + Chemotherapy in mNSCLC

      14:42 - 14:52  |  Presenter: Solange Peters

      • Abstract

      Loading...

    • +

      OA15.05 - HUDSON: An Open-Label, Multi-Drug, Biomarker-Directed Phase 2 Study in NSCLC Patients Who Progressed on Anti-PD-(L)1 Therapy

      14:52 - 15:02  |  Presenter: Benjamin Besse

      • Abstract

      Loading...

    • +

      OA15.06 - Pooled Analysis of Outcomes With Second-Course Pembrolizumab Across 5 Phase 3 Studies of Non-Small-Cell Lung Cancer

      15:02 - 15:12  |  Presenter: Delvys Rodriguez-Abreu

      • Abstract

      Loading...

    • +

      OA15.07 - Discussant

      15:12 - 15:22  |  Presenter: Puey Ling Chia

      • Abstract

      Loading...

    • +

      OA15.08 - Live Q&A

      15:22 - 15:30

      • Abstract

      Loading...